Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies

Seminars in Oncology

Volumn 39, Issue 1, 2012, Pages 109-122

  McDevitt, Michael A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HISTONE DEACETYLASE INHIBITOR; SUPPRESSOR OF CYTOKINE SIGNALING 1; UVOMORULIN; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER SURVIVAL; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; GENE MUTATION; HUMAN; MUTATION; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PRIORITY JOURNAL;

CPG ISLANDS; EPIGENOMICS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856366956     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.11.003     Document Type: Article

References (109)

1. A.M. Brske, L. Vockentanz, S. Kharazi DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction Nat Genet 41 2009 1207 1215
2. J.J. Trowbridge, J.W. Snow, J. Kim, S.H. Orkin DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells Cell Stem Cell 5 2009 442 449
3. H. Ji, L.I. Ehrlich, J. Seita Comprehensive methylome map of lineage commitment from haematopoietic progenitors Nature 467 2010 338 342
4. T. Jenuwein, C.D. Allis Translating the histone code Science 293 2001 1074 1080 (Pubitemid 32758077)
5. M.V. Iorio, C. Piovan, C.M. Croce Interplay between microRNAs and the epigenetic machinery: an intricate network Biochim Biophys Acta 1799 2010 694 701
6. A. Lujambio, A. Portela, J. Liz CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer Oncogene 29 2010 6390 6401
7. S.H. Swerdlow, E. Campo, N.L. Harris WHO classification of tumours of haematopoietic and lymphoid tissue 2008 IARC Lyon, France
8. J.P. Maciejewski, G.J. Mufti Whole genome scanning as a cytogenetic tool in hematologic malignancies Blood 112 2008 965 974
9. C. O'Keefe, M.A. McDevitt, J.P. Maciejewski Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies Blood 115 2010 2731 2739
10. R.V. Tiu, L.P. Gondek, C.L. O'Keefe New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia J Clin Oncol 27 2009 5219 5226
11. R.V. Tiu, L.P. Gondek, C.L. O'Keefe Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies Blood 2011 Feb 1 www.blood.org
12. A.M. Jankowska, H. Szpurka, R.V. Tiu Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms Blood 113 2009 6403 6410
13. T. Ernst, A.J. Chase, J. Score Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Nat Genet 42 2010 722 726
14. H. Makishima, A.M. Jankowska, R.V. Tiu Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies Leukemia 24 2010 1799 1804
15. H. Yan, D.W. Parsons, G. Jin IDH1 and IDH2 mutations in gliomas N Engl J Med 360 2009 765 773
16. E.R. Mardis, L. Ding, D.J. Dooling Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 361 2009 1058 1066
17. R. Bejar, R. Levine, B.L. Ebert Unraveling the molecular pathophysiology of myelodysplastic syndromes J Clin Oncol 29 2011 504 515
18. G. Marcucci, T. Haferlach, H. Dhner Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications J Clin Oncol 29 2011 475 486
19. S. Jones, X. Zhang, D.W. Parsons, J.C. Lin, R.J. Leary, P. Angenendt Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
20. R. Sikorski, B. Yao Visualizing the landscape of selection biomarkers in current phase III oncology clinical trials Sci Transl Med 2 2010 34ps27
21. S.B. Baylin, E.R. Fearon, B. Vogelstein Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies Blood 70 1987 412 417 (Pubitemid 17142924)
22. J.G. Herman, J.R. Graff, S. Myhnen, B.D. Nelkin, S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci U S A 93 1996 9821 9826 (Pubitemid 26296693)
23. C.A. Eads, P.W. Laird Combined bisulfite restriction analysis (COBRA) Methods Mol Biol 200 2002 71 85
24. P.A. Callinan, A.P. Feinberg The emerging science of epigenomics Hum Mol Genet 15 Spec No 1 2006 R95 R101
25. M.L. Gonzalgo, G. Liang Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation Nat Protoc 2 2007 1931 1936 (Pubitemid 47308131)
26. V.J. Bailey, B.P. Keeley, C.R. Razavi, E. Griffiths, H.E. Carraway, T.H. Wang DNA methylation detection using MS-qFRET, a quantum dot-based nanoassay Methods 52 2010 237 241
27. J.G. Herman, J. Jen, A. Merlo, S.B. Baylin Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B Cancer Res 56 1996 722 727
28. Y. Oki, J.P. Issa Epigenetic mechanisms in AMLa target for therapy Cancer Treat Res 145 2010 19 40
29. I.H. Wong, M.H. Ng, D.P. Huang, J.C. Lee Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications Blood 95 2000 1942 1949 (Pubitemid 30151630)
30. B. Quesnel, G. Guillerm, R. Vereecque Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression Blood 91 1998 2985 2990 (Pubitemid 28227550)
31. D.H. Christiansen, M.K. Andersen, J. Pedersen-Bjergaard Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia Leukemia 17 2003 1813 1819 (Pubitemid 37185257)
32. E.F. Rodrigues, C.B. Santos-Rebouas, M.M. Gonalves Pimentel Epigenetic alterations of p15(INK4B) and p16(INK4A) genes in pediatric primary myelodysplastic syndrome Leuk Lymphoma 51 2010 1887 1894
33. E.E. Cameron, K.E. Bachman, S. Myhnen, J.G. Herman, S.B. Baylin Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 21 1999 103 107 (Pubitemid 29036293)
34. S.D. Gore, S. Baylin, E. Sugar Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms Cancer Res 66 2006 6361 6369
35. M. Daskalakis, T.T. Nguyen, C. Nguyen Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′- deoxycytidine (decitabine) treatment Blood 100 2002 2957 2964
36. T.E. Fandy, J.G. Herman, P. Kerns Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies Blood 114 2009 2764 2773
37. E.E. Cameron, S.B. Baylin, J.G. Herman p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing Blood 94 1999 2445 2451 (Pubitemid 29467693)
38. J. Bies, M. Sramko, J. Fares Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia Blood 116 2010 979 987
39. M. Tessema, F. Lnger, J. Dingemann, A. Ganser, H. Kreipe, U. Lehmann Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML) Leukemia 17 2003 910 918 (Pubitemid 36626319)
40. H. Agherbi, A. Gaussmann-Wenger, C. Verthuy, L. Chasson, M. Serrano, M. Djabali Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence PLoS One 4 2009 e5622
41. H. Li, M. Collado, A. Villasante The Ink4/Arf locus is a barrier for iPS cell reprogramming Nature 460 2009 1136 1139
42. T.A. Paul, J. Bies, D. Small, L. Wolff Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML Blood 115 2010 3098 3108
43. W. Yu, D. Gius, P. Onyango Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA Nature 451 2008 202 206
44. N. Popov, J. Gil Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health Epigenetics 5 2010 685 690
45. K.L. Yap, S. Li, A.M. Muoz-Cabello Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a Mol Cell 38 2010 662 674
46. C.R. Geyer Strategies to re-express epigenetically silenced p15(INK4b) and p21(WAF1) genes in acute myeloid leukemia Epigenetics 5 2010 696 703
47. P.G. Corn, B.D. Smith, E.S. Ruckdeschel, D. Douglas, S.B. Baylin, J.G. Herman E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia Clin Cancer Res 6 2000 4243 4248
48. Y. Ye, M.A. McDevitt, M. Guo Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies Cancer Res 69 2009 8482 8490
49. E.A. Griffiths, S.D. Gore, C.M. Hooker Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia Epigenetics 5 2010 590 600
50. J.C. Desmond, S. Raynaud, E. Tung, W.K. Hofmann, T. Haferlach, H.P. Koeffler Discovery of epigenetically silenced genes in acute myeloid leukemias Leukemia 21 2007 1026 1034 (Pubitemid 46672080)
51. T.X. Liu, M.W. Becker, J. Jelinek Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation Nat Med 13 2007 78 83 (Pubitemid 46067389)
52. J.G. Herman, S.B. Baylin Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 349 2003 2042 2054 (Pubitemid 37448928)
53. M. Lbbert, P. Wijermans, R. Kunzmann, G. Verhoef, A. Bosly, C. Ravoet Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2′-deoxycytidine Br J Haematol 114 2001 349 357 (Pubitemid 32762234)
54. K. Raj, A. John, A. Ho CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine Leukemia 21 2007 1937 1944 (Pubitemid 47299967)
55. F. Ravandi, J.P. Issa, G. Garcia-Manero Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities Cancer 115 2009 5746 5751
56. H. Yoshikawa, K. Matsubara, G.S. Qian SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity Nat Genet 28 2001 29 35 (Pubitemid 32405812)
57. K. Brakensiek, F. Lnger, B. Schlegelberger, H. Kreipe, U. Lehmann Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome Br J Haematol 130 2005 209 217 (Pubitemid 41602521)
58. E. Jost, O.N. do, E. Dahl Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders Leukemia 21 2007 505 510
59. L. Teofili, M. Martini, T. Cenci Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases Int J Cancer 123 2008 1586 1592
60. N. Fourouclas, J. Li, D.C. Gilby Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders Haematologica 93 2008 1635 1644
61. S. Verstovsek, H. Kantarjian, R.A. Mesa Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis N Engl J Med 363 2010 1117 1127
62. M.J. Nemeth, D.M. Bodine Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways Cell Res 17 2007 746 758 (Pubitemid 47409701)
63. Y. Kawano, R. Kypta Secreted antagonists of the Wnt signalling pathway J Cell Sci 116 2003 2627 2634 (Pubitemid 36857216)
64. Y. Wang, A.V. Krivtsov, A.U. Sinha The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML Science 327 2010 1650 1653
65. H. Suzuki, D.N. Watkins, K.W. Jair Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat Genet 36 2004 417 422 (Pubitemid 38437267)
66. E. Jost, J. Schmid, S. Wilop Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia Br J Haematol 142 2008 745 753
67. A. Valencia, J. Roman-Gomez, J. Cervera Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia Leukemia 23 2009 1658 1666
68. E.A. Griffiths, S.D. Gore, C. Hooker Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation Leuk Lymphoma 51 2010 1711 1719
69. M. Weller, R. Stupp, G. Reifenberger MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 6 2010 39 51
70. M.E. Hegi, A.C. Diserens, T. Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003 (Pubitemid 40349502)
71. M. Esteller, R.A. Risques, M. Toyota Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis Cancer Res 61 2001 4689 4692 (Pubitemid 32691877)
72. J.R. Melki, P.C. Vincent, S.J. Clark Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia Cancer Res 59 1999 3730 3740 (Pubitemid 29381880)
73. M. Toyota, K.J. Kopecky, M.O. Toyota, K.W. Jair, C.L. Willman, J.P. Issa Methylation profiling in acute myeloid leukemia Blood 97 2001 2823 2829
74. H. Noushmehr, D.J. Weisenberger, K. Diefes Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma Cancer Cell 17 2010 510 522
75. O. Galm, S. Wilop, C. Lders Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia Ann Hematol 84 Suppl 1 2005 39 46
76. L. Shen, H. Kantarjian, Y. Guo DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes J Clin Oncol 28 2010 605 613
77. M.V. Brock, C.M. Hooker, E. Ota-Machida DNA methylation markers and early recurrence in stage I lung cancer N Engl J Med 358 2008 1118 1128 (Pubitemid 351398486)
78. H. Kroeger, J. Jelinek, M.R. Estcio Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse Blood 112 2008 1366 1373
79. S. Agrawal, M. Unterberg, S. Koschmieder DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia Cancer Res 67 2007 1370 1377
80. L.J. Rush, Z. Dai, D.J. Smiraglia Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci Blood 97 2001 3226 3233
81. S. Baylin, T.H. Bestor Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1 2002 299 305 (Pubitemid 41039130)
82. P.A. Jones, S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428 (Pubitemid 34587077)
83. M.R. Estcio, J. Gallegos, C. Vallot Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer Genome Res 20 2010 1369 1382
84. C.R. Huang, A.M. Schneider, Y. Lu Mobile interspersed repeats are major structural variants in the human genome Cell 141 2010 1171 1182
85. K.M. McGarvey, L. Van Neste, L. Cope Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells Cancer Res 68 2008 5753 5759
86. J.C. Desmond, S. Raynaud, E. Tung, W.K. Hofmann, T. Haferlach, H.P. Koeffler Discovery of epigenetically silenced genes in acute myeloid leukemias Leukemia 21 2007 1026 1034 (Pubitemid 46672080)
87. S. Agrawal, W.K. Hofmann, N. Tidow The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia Blood 109 2007 3895 3905 (Pubitemid 46641742)
88. L. Shen, Y. Kondo, S. Ahmed Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel Cancer Res 67 2007 11335 11343 (Pubitemid 350248560)
89. D.J. Smiraglia, L.J. Rush, M.C. Frhwald Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies Hum Mol Genet 10 2001 1413 1419 (Pubitemid 32640670)
90. Y. Jiang, A. Dunbar, L.P. Gondek Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Blood 113 2009 1315 1325
91. M.E. Figueroa, L. Skrabanek, Y. Li MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation Blood 114 2009 3448 3458
92. M.E. Figueroa, S. Lugthart, Y. Li DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia Cancer Cell 17 2010 13 27
93. M.E. Figueroa, O. Abdel-Wahab, C. Lu Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 2010 553 567
94. L. Bullinger, M. Ehrich, K. Dhner Quantitative DNA methylation predicts survival in adult acute myeloid leukemia Blood 115 2010 636 642
95. T. Ernst, A.J. Chase, J. Score Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Nat Genet 42 2010 722 726
96. G. Nikoloski, S.M. Langemeijer, R.P. Kuiper Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes Nat Genet 42 2010 665 667
97. H. Makishima, A.M. Jankowska, R.V. Tiu Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies Leukemia 24 2010 1799 1804
98. G. van Haaften, G.L. Dalgliesh, H. Davies Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer Nat Genet 41 2009 521 523
99. L.D. Wartman, D.E. Larson, Z. Xiang Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression J Clin Invest 121 2011 1445 1455
100. R.J. Gibbons, D.J. Picketts, L. Villard, D.R. Higgs Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome) Cell 80 1995 837 845
101. M.S. Davids, D.P. Steensma The molecular pathogenesis of myelodysplastic syndromes Cancer Biol Ther 10 2010 309 319
102. D.B. Costa, C.A. Fisher, K.B. Miller A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome Eur J Haematol 76 2006 432 435
103. T.J. Ley, L. Ding, M.J. Walter DNMT3A mutations in acute myeloid leukemia N Engl J Med 363 2010 2424 2433
104. X.J. Yan, J. Xu, Z.H. Gu Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia Nat Genet 43 2011 309 315
105. C.Z. Chen, H.F. Lodish MicroRNAs as regulators of mammalian hematopoiesis Semin Immunol 17 2005 155 165 (Pubitemid 40292054)
106. S. Guo, J. Lu, R. Schlanger MicroRNA miR-125a controls hematopoietic stem cell number Proc Natl Acad Sci U S A 107 2010 14229 14234
107. S. Mi, J. Lu, M. Sun MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia Proc Natl Acad Sci U S A 104 2007 19971 19976
108. B. Hackanson, K.L. Bennett, R.M. Brena Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia Cancer Res 68 2008 3142 3151
109. J.M. Friedman, G. Liang, C.C. Liu The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2 Cancer Res 69 2009 2623 2629